Navigation Links
Plant stem cells could be fruitful source of low-cost cancer drug
Date:10/25/2010

A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.

Researchers have isolated and grown stem cells from a yew tree whose bark is a natural source of the anticancer compound paclitaxel. The development could enable the compound to be produced on a commercial scale at low cost, with no harmful by-products.

Scientists and engineers behind the development say the drug treatment currently used on lung, ovarian, breast, head and neck cancer could become cheaper and more widely available. The study was carried out by the University of Edinburgh and the Unhwa Biotech company in Korea.

Currently, an extract from yew tree bark is used to industrially manufacture the compound paclitaxel. However, this process is expensive, requires supplies of mature trees, and creates environmentally damaging by-products.

Researchers claim that using stem cells self-renewing tree cells which can be manipulated to produce large amounts of the active compound would effectively create an abundant supply of the drug. The process would cost far less than conventional methods.

Scientists behind the project have also cultured stem cells from other plants with medical applications, indicating that the technique could be used to manufacture other important pharmaceuticals besides paclitaxel.

The study was published in Nature Biotechnology and supported by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council.

Professor Gary Loake, of the University of Edinburgh's School of Biological Sciences, who led/took part in the study, said: "Plants are a rich source of medicine around one in four drugs in use today is derived from plants. Our findings could deliver a low-cost, clean and safe way to harness the healing power of plants, potentially helping to treat cancer, and other conditions."


'/>"/>

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh
Source:Eurekalert

Related medicine news :

1. Studies show everolimus-eluting stent implantation reduces restenosis and repeat revasculariztion
2. Vitamin D deficiency linked to lung transplant rejection
3. OHSU research suggests compound administered during some bone marrow transplants elevates risks
4. Kings College London reveals promising techniques for extending the life of an organ transplant
5. Southampton to conduct UKs first cochlear implant operation to give sound in both ears
6. Biosynthetic Corneas Show Promise in Transplants
7. Decade-long trial confirms benefts of steroid withdrawal for transplant patients
8. Hispanics and Asians less likely to receive liver transplants
9. Study identifies factors which predict alcohol use after liver transplantation
10. Chronic health conditions common for stem cell transplant survivors
11. Plant compound resveratrol shown to suppresses inflammation, free radicals in humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated ... latest FDA requirements, which stipulates new criteria regarding medical device manufacture ... Medical ID jewelry such as Medical ID Bracelets, can rest assured ... of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process ...
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
Breaking Medicine Technology: